Genital herpes in young adults: Changing sexual behaviours, epidemiology and management

Herpes

Volumn 12, Issue 1, 2005, Pages 10-14

  Roberts, Craig M ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University Health Services   (United States)

Author keywords

Adolescents; Epidemiology; Genital herpes; Herpes simplex virus 1 (HSV1); Herpes simplex virus 2 (HSV 2); Seroprevalence; Sexually transmitted infections; Young adults

Indexed keywords

ACICLOVIR; FAMCICLOVIR; NUCLEOSIDE ANALOG; VALACICLOVIR;

ADOLESCENCE; ADOLESCENT; AGE; CONDOM; CONFERENCE PAPER; DISEASE SEVERITY; EARLY DIAGNOSIS; EPIDEMIC; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HUMAN; INFECTION PREVENTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHOSEXUAL DEVELOPMENT; RISK FACTOR; SCREENING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS SHEDDING; VIRUS TRANSMISSION;

HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HUMANS; SEXUAL BEHAVIOR;

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2;

EID: 20844448177     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181:1454-1457.
2. Stanberry LR, Rosenthal SL. The epidemiology of herpes simplex virus infections in adolescents. Herpes 1999;6: 12-15.
3. Genital herpes simplex virus type 1 infection. In: The Management of HSV-1 and Ocular HSV Diseases: Recommendations from the IHMF Management Strategies Workshop (Malkin J-E, Stanberry LR, eds), International Herpes Management Forum. Worthing: PAREXEL MMS, 2002;pp28-38.
4. Suligoi B, Cusini M, Ghislanzoni M, Vezzoli P, Alessi E. Genital herpes caused by HSV-1 increase in Milan, Italy. Abstract HSV-01. 11th Annual Meeting of the IHMF; Amsterdam, The Netherlands, 2004. Herpes 2005;11:21.
5. Manavi K, McMillan A, Ogilvie M. Herpes simplex virus type 1 remains the principal cause of initial anogenital herpes in Edinburgh, Scotland. Sex Transm Dis 2004;31:322-324.
6. Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Dis 2003;30:794-796.
7. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003;30: 797-800.
8. Forward KR. Recovery rates of herpes simplex type 1 (HSV-1) from patients with genital herpes in Nova Scotia. Abstracts of the 42nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30, 2002; San Diego, California. Abstract L-771.
9. Thompson C. Genital herpes simplex typing in genitourinary medicine: 1995-1999. Int J STD AIDS 2000;11:501-502.
10. Lowhagen GB, Tunback P, Andersson K, Bergstrom T, Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 2000;76: 179-182.
11. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000;79:693-696.
12. Kawana T. 29 years' experience of clinical and virological studies on female genital herpes in Japan. Abstract HSV-02. 11th Annual Meeting of the IHMF; Amsterdam, The Netherlands, 2004. Herpes 2005;11:21.
13. Ribes JA, Steele AD, Seabolt JP, Baker DJ. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population. J Clin Microbiol 2001;39: 3321-3325.
14. Corey L, Wald A. Genital Herpes. In: Sexually Transmitted Diseases. 3rd edn (Holmes KK, Mardh PA, Sparling PF et al. eds). New York: McGraw-Hill, 1999: 285-312.
15. Wald A, Zeh J, Selke S, Warren T, Ryncarz AJ, Ashley R et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000;342:844-850.
16. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770-775.
17. Langenberg AG, Corey L, Ashley R, Leong WP, Strauss SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341: 1432-1438.
18. Engelberg R, Carrel D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003;30:174-177.
19. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
20. Mertz GJ, Coombs RW, Ashley RL, Jourden J, Remington M, Winter C et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner: a prospective study. J Infect Dis 1988;157:1169-1177.
21. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337: 509-515.
22. Wasserheit J. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
23. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2 seropositive persons: a meta-analysis. J Infect Dis 2002;185: 45-52.
24. Wald A. Synergistic interactions between herpes simplex virus type-2 and human immunodeficiency virus epidemics. Herpes 2004;11:70-75.
25. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Synd 2004;35:435-445.
26. Malkin J-E. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004;11 (Suppl 1):2A-23A.
27. Weiss H. Epidemiology of herpes simplex virus type 2 in the developing world. Herpes 2004;11(Suppl 1): 24A-35A.
28. Stanberry LR, Jorgensen DM, Nahmias AJ. Herpes simplex viruses 1 and 2. In: Viral Infections of Humans: Epidemiology and Control, 4th edn (Evans AS, Kaslow RA, eds). New York: Plenum Medical 1997:pp419-454.
29. American Social Health Association. Sexually transmitted diseases in America: how many cases and at what cost? Report prepared for the Kaiser Family Foundation. December, 1998.
30. Bearman PS, Moody J, Stovel K. Chains of affection: the structure of adolescent romantic and sexual networks. Am J Social 2004;110:44-91.
31. Doherty IA, Padian NS, Marlow C, Aral SO. Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections. J Infect Dis. 2005;191 (Suppl 1):S42-S54.
32. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337: 1105-1111.
33. Herpes simplex virus type 2: programmatic and research priorities in developing countries. Report of a WHO/UNAIDS/LSHTM workshop, London, February 14-16, 2001. Geneva: World Health Organization 2001.
34. Stanberry LR, Rosenthal SL. Genital herpes simplex virus infection in the adolescent: special considerations for management. Pediatr Drugs 2002;4:291-297.
35. Armstrong, GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001;153:912-920.
36. Weinstock H, Berman S, Cates W, Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10.
37. Cherpes TL, Meyn LA, Hillier SL. Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women. Sex Transm Dis 2005;32:84-89.
38. Schillinger JA, Xu F, Sternberg MR, Armstrong GL, Lee FK, Nahmias AJ et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis 2004;31:753-760.
39. Lamey P-J, Hyland PL. Changing epidemiology of herpes simplex virus type 1 infections. Herpes 1999;6: 20-24.
40. Whitley RJ, Gnann JW. The human herpesviruses. In: The Human Herpesviruses. (Roizman B, Whitley RJ, Lopez C, eds). New York: Raven, 1993:pp69-105.
41. Warren T. Importance and practicalities of patient counseling in the prevention and management of genital herpes. Medscape Infectious Diseases 2004;6(2). Available at http://www.medscape.com/viewarticle/489964?src= search〉 Last accessed 12 April 2005.
42. American College Health Association. National College Health Assessment: Reference Group Executive Summary, Spring 2000. Baltimore: American College Health Association, 2001.
43. Gates GL, Sonenstein FL. Heterosexual genital sexual activity among adolescent males: 1988 and 1995. Fam Plann Perspect 2000;32: 295-304.
44. Bernstein N. In a culture of sex, more teenagers are striving for restraint. The New York Times, 7 March 2004.
45. Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001;285:3100-3106.
46. Douglas KA, Collins JL, Warren C, Kann L, Gold R, Clayton S et al. Results from the 1995 National College Health Risk Behavior Survey. J Am Coll Health 1997;46: 55-66.
47. Sonenstein FL, Leighton K, Duberstein Lindberg L, Turner CF, Fleck JH. Changes in sexual behavior and condom use among teenage males: 1988 to 1995. Am J Pub Health 1998;88:956-959.
48. Shafii T, Stovel K, Davis R, Holmes KK. Is condom use habit-forming? Condom use at sexual debut and subsequent condom use. Sex Transm Dis 2004;31:366-372.
49. Bruckner H, Bearman P. After the promise: the STD consequences of adolescent virginity pledges. J Adolesc Health 2005;36:271-278.
50. Xu F, McQuillan G, Kottiri B, Sternberg M, Lee F, Nahmias A et al. Trends in herpes simplex virus type 2 infection in the United States (Abstract C03C). Abstracts of the 2004 National STD Prevention Conference, Philadelphia, PA, 2004.
51. Carney O, Ross E, Bunker C, Ikkos G, Mindel A. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med 1994;70:40-45.
52. Swanson JM. The biopsychosocial burden of genital herpes: evidence-based and other approaches to care. Dermatol Nurs 1999;11:257-268.
53. Alexander L, Naisbett B. Patient and physician partnerships in managing genital herpes. J Infect Dis 2002;186(suppl 1):S57-S65.
54. Lafferty WE. The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing. Herpes 2002;9:51-55.
55. Ashley RL. Sorting out the new HSV type specific antibody tests. Sex Transm Infect 2001;77:232-237.
56. Guerry S, Allen B, Branagan B, Kerndt P, Klausner J, Bauer H et al. (eds). Guidelines for the Use of Herpes Simplex Virus (HSV) Type 2 Serologies: Recommendations from the California Sexually Transmitted Diseases (STD) Controllers Association and the California Department of Health Services (CA DHS). California STD/HIV Prevention Training Center, 2003.
57. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002;51(RR-6):14.
58. Benedetti J, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999;131:14-20.
59. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996;124: 8-15.
60. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
61. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003;187: 1513-1521.